Funding Opportunities

PDBP Funding opportunities (FOAs) support discovery projects designed to promote the identification of promising diagnostic and progression biomarkers for Parkinson's disease.

The NINDS Human Cell and Data Repository (U24 - Clinical Trial Not Allowed)

Annoucement Type:
Reissue of RFA-NS-15-009
Application Due Date:
Activity Code:
U24
Letter of Intent Due Date:
FOA Number:
RFA-NS-19-038
Contact:
Christine Swanson-Fischer, PhD

Funding Opportunity Purpose

This Funding Opportunity Announcement (FOA) invites applications to support the National Institute of Neurological Disorders and Stroke (NINDS) Human Cell and Data Repository (NHCDR). The repository will maintain the current collection of fibroblast and induced pluripotent stem cell (iPSC) lines as well as develop, characterize, expand source cells and iPSCs, and where appropriate, genetically modify new high-quality iPSC lines in accordance with the NINDS mission. The NINDS Human Cell and Data Repository will distribute human cell resources broadly to qualified academic and industry researchers to advance basic and translational research in neurological disorders.

Peripheral Pathology in the Lewy Body Dementias (R01 Clinical Trial Not Allowed)

Annoucement Type:
New
Application Due Date:
Activity Code:
R01
FOA Number:
RFA-NS-20-014
Contact:
Debra Babcock, PhD, MD

Funding Opportunity Purpose

The purpose of this initiative is to identify potential diagnostic markers for the Lewy Body Dementias using non-blood or non-CSF peripheral specimens and tissues (e.g., skin, salivary gland, gastrointestinal tract, etc.). Blood and CSF have traditionally and extensively been examined for neurodegenerative disease biomarkers; however, research suggests that abnormal alpha-synuclein accumulation occurs in other peripheral tissues and specimens early in the disease course and may provide opportunities for early diagnosis and future treatment development.